Business Context and Reporting Period
This Form 8-K Current Report was filed by iBio, Inc. on January 16, 2020, regarding events occurring on January 10, 2020. The filing addresses the Company's status with NYSE American LLC concerning continued listing standards.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin figures for the current period. However, it references historical financial conditions that triggered listing non-compliance notices:
- Stockholders' Equity: Previously reported as less than $2,000,000 (triggering Section 1003(a)(i) non-compliance).
- Net Losses: The Company has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years.
- Share Price: The Exchange determined the securities have been selling for a low price per share for a substantial period.
Material Changes and Listing Status
On January 10, 2020, NYSE Regulation accepted the Company's plan to regain compliance with continued listing standards. Key details include:
- Plan Period: Granted through December 9, 2020, subject to quarterly monitoring.
- Compliance Requirements: The Company must meet standards regarding stockholders' equity and net losses (Sections 1003(a)(i), (ii), and (iii)).
- Share Price Requirement: The Company must effect a reverse stock split or demonstrate sustained share price improvement by June 9, 2020 (Section 1003(f)(v)).
- Delisting Risk: If the Company fails to comply by December 9, 2020, or fails to make consistent progress, delisting proceedings will be initiated.
Outlook and Management Commentary
Management announced the acceptance of the compliance plan via a press release on January 16, 2020. The filing states that the acceptance has no immediate impact on the listing, which is continued pursuant to the extension during the plan period. The Company faces a critical deadline of June 9, 2020, to address low share price issues.
Investor Verification Checklist
- Verify the Company's progress on the compliance plan through quarterly monitoring reports.
- Monitor share price performance to ensure compliance with the June 9, 2020, deadline for price improvement or a reverse stock split.
- Review upcoming financial statements to confirm if stockholders' equity has risen above the $2,000,000 threshold.
- Check for any announcements regarding a reverse stock split prior to June 2020.